Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Menopause (New York, N.Y.)|September 21, 2007
The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen statusPratima Gupta, Begüm Ozel, Frank Z Stanczyk, et al.Contraception|January 29, 2013
Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptivesHeather Fels, Rachel Steward, Alexander Melamed, et al.Contraception|May 18, 2010
Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneouslyPenina Segall-Gutierrez, DeShawn Taylor, Xinwen Liu, et al.Contraception|June 23, 2004
Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-ProveraJohn Jain, Caryn Dutton, Antonia Nicosia, et al.Current Medical Research and Opinion|May 19, 2005
Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: a consensus reportBruce S Kahn, Edward J Stanford, Daniel R Mishell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 13, 2013
Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected womenJessica Atrio, Frank Z Stanczyk, Michael Neely, et al.Contraception|February 3, 2009
Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetateRadhika D Rible, DeShawn Taylor, Melissa L Wilson, et al.Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Assessment of internet-based information regarding pelvic organ prolapse and urinary incontinenceSteven Minaglia, Bliss Kaneshiro, Karen Soules, et al.Menopause (New York, N.Y.)|May 3, 2011
Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladderRebecca S Nelken, Begüm Z Ozel, Ava R Leegant, et al.Journal of Community Health|October 31, 2015
Development of a Cost-Effective Educational Tool to Promote Acceptance of the HPV Vaccination by Hispanic MothersDoerthe Brueggmann, Neisha Opper, Juan Felix, et al.Pageof 6